Cart
sales@molnova.com
MYF-01-37
CAS No. 2416417-65-5
MYF-01-37( 1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one )
Catalog No. M24113 CAS No. 2416417-65-5
MYF-01-37 is a novel covalent TEAD inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 58 | In Stock |
|
| 2MG | 32 | In Stock |
|
| 5MG | 52 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 169 | In Stock |
|
| 50MG | 291 | In Stock |
|
| 100MG | 435 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 918 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMYF-01-37
-
NoteResearch use only, not for human use.
-
Brief DescriptionMYF-01-37 is a novel covalent TEAD inhibitor.
-
DescriptionMYF-01-37 is a novel covalent TEAD inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms1-[3-Methyl-3-[3-(trifluoromethyl)anilino]pyrrolidin-1-yl]prop-2-en-1-one
-
PathwayOthers
-
TargetOther Targets
-
RecptorTEAD
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2416417-65-5
-
Formula Weight298.3
-
Molecular FormulaC15H17F3N2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (838.08 mM)
-
SMILESCC(CC1)(CN1C(C=C)=O)Nc1cccc(C(F)(F)F)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kurppa K J , Liu Y , To C , et al. Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway[J]. Cancer Cell, 2020, 37(1):104-122.e12.
molnova catalog
related products
-
TBMP
TBMP is the viral envelope protein hemagglutinin (HA)-mediated entry novel inhibitor.
-
GSK962
GSK962 is a GSK963 inactive enantiomer. It can be used to confirm the on-target effects.
-
2'-Deoxyinosine
it is used to treat HIV infection with other antiviral drugs.
